A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

D. Scott McMeekin, Alan N. Gordon, Jeffrey M. Fowler, Allen S. Melemed, Richard E. Buller, Thomas J. Burke, Paul Sabbatini

Gynecologic Oncology · 2003 · 82 citations · 20 references

Concepts

References

20